Other
Change in AR
Amgen Change in AR decreased by 138.4% to -$413.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 131.6%, from $1.31B to -$413.00M. Over 3 years (FY 2021 to FY 2025), Change in AR shows an upward trend with a 89.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A significant increase may signal aggressive revenue recognition or collection issues, while a decrease suggests improved cash conversion cycles.
Detailed definition
The net change in the balance of accounts receivable during the reporting period, representing the difference between cr...
Peer comparison
Should track closely with revenue growth; significant deviations from revenue trends warrant investigation.
Metric ID:
anet_change_in_accounts_receivableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $304.00M | $160.00M | $195.00M | $309.00M | $62.00M | $180.00M | $144.00M | $96.00M | $342.00M | $433.00M | -$486.00M | $342.00M | -$473.00M | $1.31B | $515.00M | $0.00 | $1.08B | -$413.00M |
| QoQ Change | — | +442.9% | -47.4% | +21.9% | +58.5% | -79.9% | +190.3% | -20.0% | -33.3% | +256.3% | +26.6% | -212.2% | +170.4% | -238.3% | +376.5% | -60.6% | -100.0% | — | -138.4% |
| YoY Change | — | — | — | — | +451.8% | -79.6% | +12.5% | -26.2% | -68.9% | +451.6% | +140.6% | -437.5% | +0.0% | -209.2% | +369.1% | — | -100.0% | +327.3% | -131.6% |
Range-$486.00M – $1.31B
CAGR+55.9%
Avg YoY Growth+50.0%
Median YoY Growth-13.1%
Change in AR at Other Companies
Frequently Asked Questions
- What is Amgen's change in ar?
- Amgen (AMGN) reported change in ar of -$413.00M in Q1 2026.
- How has Amgen's change in ar changed year-over-year?
- Amgen's change in ar decreased by 131.6% year-over-year, from $1.31B to -$413.00M.
- What is the long-term trend for Amgen's change in ar?
- Over 3 years (2021 to 2025), Amgen's change in ar has grown at a 89.0% compound annual growth rate (CAGR), from $429.00M to $2.90B.
- What does change in ar mean?
- The net increase or decrease in money owed to the company by customers.